Get started
NOVARTIS AG CEDEAR EAC 4 REP 1(USD)NOVARTIS AG CEDEAR EAC 4 REP 1(USD)NOVARTIS AG CEDEAR EAC 4 REP 1(USD)

NOVARTIS AG CEDEAR EAC 4 REP 1(USD)

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals Bonds

NVSD chart


Full chart

Key stats


Market capitalization
‪193.07 B‬ USD
Dividend yield (indicated)
1.95%
Price to earnings Ratio (TTM)
2.965
Basic EPS (TTM)
9.012 USD
Net income (FY)
‪15.85 B‬ USD
Revenue (FY)
‪48.50 B‬ USD
Shares float
‪1.75 B‬
Beta (1Y)
0.44

About NOVARTIS N


Sector
Health Technology
CEO
Vasant Narasimhan
Headquarters
Basel
Website
novartis.com
Founded
1996
ISIN
ARDEUT112521
FIGI
BBG000PM0ND8
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment includes researching, distributing and selling patented pharmaceuticals. The Sandoz segment focuses on marketing finished dosage form medicines and intermediary products including active pharmaceutical ingredients. The Corporate segment is involved in group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

NVSD news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

NVSD highest yielding bonds


N
US66989HAS7
NOVARTIS CAP 20/50
Yield to maturity
6.69%
Maturity date
Aug 14, 2050
N
XPND
NOVARTIS CAPITAL 15/45
Yield to maturity
5.95%
Maturity date
Nov 20, 2045
N
NVS3904288
Novartis Capital Corp. 3.7% 21-SEP-2042
Yield to maturity
5.95%
Maturity date
Sep 21, 2042
N
US66989HAH1
NOVARTIS CAPITAL 14/44
Yield to maturity
5.82%
Maturity date
May 6, 2044
N
NVS5894401
Novartis Capital Corp. 4.7% 18-SEP-2054
Yield to maturity
5.74%
Maturity date
Sep 18, 2054
N
NVS5894400
Novartis Capital Corp. 4.2% 18-SEP-2034
Yield to maturity
5.27%
Maturity date
Sep 18, 2034
N
US66989HAR9
NOVARTIS CAP 20/30
Yield to maturity
5.14%
Maturity date
Aug 14, 2030
N
NVS5894399
Novartis Capital Corp. 4.0% 18-SEP-2031
Yield to maturity
4.93%
Maturity date
Sep 18, 2031
N
NVS5894398
Novartis Capital Corp. 3.8% 18-SEP-2029
Yield to maturity
4.83%
Maturity date
Sep 18, 2029
N
US66989HAN8
NOVARTIS CAPITAL 17/27
Yield to maturity
4.69%
Maturity date
May 17, 2027
N
NVS4950565
Novartis Capital Corp. 2.0% 14-FEB-2027
Yield to maturity
4.55%
Maturity date
Feb 14, 2027

Explore more bonds 

Sparks


Curated watchlists where NVSD is featured.

See all sparks